NeuroQuant® PET: FDA 510(k)-Pending Advancement in Molecular Dementia Imaging
Advancing Quantitative PET Analysis in Dementia Imaging NeuroQuant® PET is FDA 510(k)-Pending for PET quantification and analysis in patients undergoing evaluation […]
Advancing Quantitative PET Analysis in Dementia Imaging NeuroQuant® PET is FDA 510(k)-Pending for PET quantification and analysis in patients undergoing evaluation […]
HIPAA requires that healthcare organizations prove that vendors protect electronic Protected Health Information (ePHI) entrusted to them with controls that
Overview of Updates, Modeling, Validation, and Clinical Impact The NeuroQuant normative database is designed to compare individual brain measurements with
As we enter 2026, we want to take a moment to reflect on what has been a truly impactful year
Quantitative imaging has rapidly become an integral component of clinical care—supporting earlier diagnosis, objective tracking, and improved confidence in interpretation. Our recent
Radiation therapy as an option for men with prostate cancer has been greatly improved over recent years with technological advancements
RSNA always offers a clear snapshot of where radiology is heading, and this year had a few themes: AI showing
The 2025 Society for Neuro-Oncology (SNO) meeting in Hawaii was more than a conference—it was a vibrant hub of collaboration
Quantitative neuroimaging has become a cornerstone of precision medicine. NeuroQuant automatically transforms routine MRI scans into objective volumetric measurements, empowering
As the population ages, the demand for early and accurate assessment of neurodegenerative diseases continues to grow. Clinicians are increasingly
In the realm of neuro-oncology, precision is everything. From diagnosis to treatment planning, clinicians rely on detailed imaging data to
Did you know that more than 1 million prostate biopsies are performed each year in the US alone? In order